ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Ecklonia Cava 10:1 Ormus White Powder Gold

Also known as: Ecklonia cava, brown algae, Ecklonia cava 10:1 Ormus White Powder Gold

Overview

Ecklonia cava is a species of brown seaweed predominantly found in the coastal waters of Korea and Japan. It is distinguished by its high concentration of phlorotannins, particularly dieckol, which are unique polyphenolic compounds. These compounds are responsible for the seaweed's potent antioxidant, anti-inflammatory, and neuroprotective properties. As a dietary supplement, it is often available as a concentrated extract, such as a 10:1 ratio, indicating that 10 parts of raw seaweed are concentrated into 1 part of the extract. The term "Ormus white powder gold" likely refers to a proprietary, purified powdered form of this extract. While traditionally used for various health benefits, modern research is increasingly exploring its potential in neuroprotection, metabolic health, and as a powerful antioxidant. Although in vitro and animal studies are promising, clinical evidence in humans is still emerging and requires further robust investigation.

Benefits

Ecklonia cava offers several evidence-based benefits, primarily due to its rich phlorotannin content: * **Neuroprotection and Cognitive Function:** Strong preclinical evidence suggests neuroprotective effects. An animal study demonstrated that an Ecklonia cava extract improved cognitive impairment in mice by reducing oxidative stress, enhancing mitochondrial function, and modulating inflammatory and apoptotic pathways. It also increased brain-derived neurotrophic factor (BDNF) production, which is crucial for neuronal health. While promising, these findings are from animal models and require human clinical trials for confirmation. * **Blood Glucose Regulation:** Limited human clinical evidence indicates a potential for acute blood glucose modulation. A small randomized controlled trial in 20 prediabetic individuals showed that a single 600 mg dose of Ecklonia cava extract significantly lowered postprandial blood glucose levels without reported side effects. This suggests a potential role in managing acute glycemic responses, but larger, longer-term studies are needed to confirm sustained effects. * **Antioxidant Effects:** Multiple studies consistently show that Ecklonia cava extracts, particularly their phlorotannins like dieckol, possess strong antioxidant properties. They effectively scavenge reactive oxygen species, which contributes to overall cellular protection against oxidative damage. This is a well-supported benefit across various research types. Other purported benefits, such as cholesterol lowering, cancer prevention, osteoarthritis relief, and athletic performance enhancement, currently lack strong clinical evidence.

How it works

The primary mechanism of action for Ecklonia cava is attributed to its unique phlorotannin compounds, especially dieckol. These compounds act as potent antioxidants, effectively neutralizing reactive oxygen species and reducing oxidative stress within the body. Ecklonia cava also modulates key cellular signaling pathways involved in inflammation, such as NF-κB, and apoptosis, like JNK, thereby exerting anti-inflammatory and cell-protective effects. In the brain, it enhances mitochondrial function, improving ATP production and membrane potential, and promotes the expression of synaptic proteins, contributing to its neuroprotective properties. Furthermore, it may influence carbohydrate metabolism, potentially by modulating enzyme activity or improving insulin sensitivity, leading to a reduction in postprandial blood glucose levels.

Side effects

Ecklonia cava is generally considered safe, with no significant adverse effects reported in human clinical trials at studied dosages, specifically around 600 mg. The small human trial conducted on prediabetic subjects reported no side effects following a single 600 mg dose. There are currently no major drug interactions or contraindications well-documented in high-quality scientific studies. However, it is important to note that long-term safety data for Ecklonia cava supplementation are limited, as most human studies have been short-term or acute. Individuals with known allergies to seaweed or iodine should exercise caution, although specific allergic reactions to Ecklonia cava are not widely reported. As with any supplement, pregnant or breastfeeding women, individuals with pre-existing medical conditions, or those taking medications should consult a healthcare professional before use. Due to the limited long-term data, continuous high-dose supplementation without medical supervision is not recommended.

Dosage

Based on current human research, a single dose of 600 mg of Ecklonia cava extract has been shown to acutely lower postprandial blood glucose in prediabetic individuals. This dosage was used in a randomized controlled trial and was well-tolerated with no reported side effects. However, there is no established minimum effective dose or maximum safe dose from large-scale clinical trials for other potential benefits or for long-term use. The effectiveness of Ecklonia cava supplements can vary depending on the standardization of the extract, particularly its phlorotannin content (e.g., dieckol). For blood glucose management, postprandial administration (after meals) may be relevant. Due to the limited clinical data, it is advisable to adhere to dosages used in research or as recommended by a healthcare professional. Upper limits and safety thresholds for chronic use are not yet well-defined.

FAQs

Is Ecklonia cava safe to take?

Yes, at studied doses (e.g., 600 mg), Ecklonia cava extract has been well-tolerated in human trials with no adverse effects reported. Long-term safety data are still limited.

Does Ecklonia cava improve memory or cognitive function?

Animal studies suggest neuroprotective effects and improvements in cognitive function. However, human evidence is currently lacking, and more research is needed to confirm these benefits in people.

How quickly does Ecklonia cava work?

For blood glucose regulation, acute effects have been observed within two hours post-dose in human studies. Effects for other benefits may vary and require consistent use.

Is a 10:1 extract of Ecklonia cava more potent?

A 10:1 extract indicates a higher concentration of the raw material, suggesting a potentially higher content of bioactive compounds. However, specific clinical data on the efficacy of this particular extract ratio are sparse.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC11352165/ – This animal study investigated the effects of Ecklonia cava ethanol extract on cognitive impairment in mice induced by amyloid beta. The findings showed that the extract significantly improved learning and memory, reduced oxidative stress markers, enhanced mitochondrial function, and modulated neuroinflammation and apoptosis pathways, suggesting strong neuroprotective potential.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC9922105/ – This randomized controlled trial in 20 prediabetic human subjects evaluated the acute effect of a single 600 mg dose of Ecklonia cava extract on postprandial blood glucose. The study found that the extract effectively lowered blood glucose levels after a meal without any reported side effects, indicating its potential for acute glycemic modulation.
  • https://www.frontiersin.org/journals/marine-science/articles/10.3389/fmars.2023.1287047/full – This experimental study focused on optimizing extraction parameters for dieckol, a key phlorotannin in Ecklonia cava. The research provides valuable insights into how different extraction methods (ethanol concentration, time, temperature) influence the yield of dieckol, which is crucial for producing standardized and potent Ecklonia cava supplements.
  • https://www.webmd.com/vitamins/ai/ingredientmono-1248/ecklonia-cava – This source provides a general overview of Ecklonia cava, its common uses, and a summary of available scientific evidence. It highlights the traditional uses and some of the emerging research on its health benefits, while also noting the need for more robust clinical trials.
  • https://www.jmb.or.kr/journal/view.html?uid=5823&vmd=Full – This source discusses the antioxidant properties of phlorotannins from Ecklonia cava. It reinforces the understanding that these compounds are potent scavengers of reactive oxygen species, contributing significantly to the overall antioxidant capacity of the seaweed extract.